Furthermore, the increased expression of hBD2 and LL-37 in the skin of psoriasis patients has been found to be a result of chronic inflammation, and the expression of hBD2 and inflammation may form a positive feedback loop in patients with psoriasis [49]. Here, CAMP is linked to psoriasis.